Moreover, several studies documented a strong correlation between RBP4 and both IR and dyslipidemia; as it impairs glucose tolerance and insulin sensitivity and enhances the production of the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase. Here, INS is linked to metabolic syndrome.